P450-mediated dehydrotyrosine formation during WS9326 biosynthesis proceeds via dehydrogenation of a specific acylated dipeptide substrate

Songya Zhang,Lin Zhang,Anja Greule,Julien Tailhades,Edward Marschall,Panward Prasongpholchai,Daniel J. Leng,Jingfan Zhang,Jing Zhu,Joe A. Kaczmarski,Ralf B. Schittenhelm,Oliver Einsle,Colin J. Jackson,Fabrizio Alberti,Andreas Bechthold,Youming Zhang,Manuela Tosin,Tong Si,Max J Cryle
DOI: https://doi.org/10.1016/j.apsb.2023.03.021
IF: 14.903
2023-03-31
Acta Pharmaceutica Sinica B
Abstract:WS9326A is a peptide antibiotic containing a highly unusual N -methyl- E -2-3-dehydrotyrosine (NMet-Dht) residue that is incorporated during peptide assembly on a non-ribosomal peptide synthetase (NRPS). The cytochrome P450 encoded by sas16 (P450 Sas ) has been shown to be essential for the formation of the alkene moiety in NMet-Dht, but the timing and mechanism of the P450 Sas -mediated α , β -dehydrogenation of Dht remained unclear. Here, we show that the substrate of P450 Sas is the NRPS-associated peptidyl carrier protein (PCP)-bound dipeptide intermediate ( Z )-2-pent-1′-enyl-cinnamoyl-Thr-N-Me-Tyr. We demonstrate that P450 Sas -mediated incorporation of the double bond follows N -methylation of the Tyr by the N- methyl transferase domain found within the NRPS, and further that P450 Sas appears to be specific for substrates containing the ( Z )-2-pent-1′-enyl-cinnamoyl group. A crystal structure of P450 Sas reveals differences between P450 Sas and other P450s involved in the modification of NRPS-associated substrates, including the substitution of the canonical active site alcohol residue with a phenylalanine (F250), which in turn is critical to P450 Sas activity and WS9326A biosynthesis. Together, our results suggest that P450 Sas catalyses the direct dehydrogenation of the NRPS-bound dipeptide substrate, thus expanding the repertoire of P450 enzymes that can be used to produce biologically active peptides.
pharmacology & pharmacy
What problem does this paper attempt to address?